Spark YG™ 570 anti-mouse CD206 (MMR) Antibody, CD206, C068C2,BioLegend,141738

Clone C068C2 recognizes a region similar to clone MR5D3, based on the ability of the clones to block each other. Additional reported applications (for the relevant formats) include: spatial biology (IBEX)4,5.

Host

Rat

Reactivity

Mouse

Application

IHC-F -Quality tested

Platform ID

BAB304865532

BioLegend

Headquarters

8999 BioLegend Way San Diego, CA 92121 United States

Contact

Tel: 1-858-455-9588
Fax: +49 (4131) 7023913

Email:

Product Specifications
Scientific Background

Specifications

NameSpark YG™ 570 anti-mouse CD206 (MMR) Antibody, CD206, C068C2
Cat. No.141738
HostRat
RRIDAB_2832510 (BioLegend Cat. No. 141737)AB_2860694 (BioLegend Cat. No. 141738)
IsotypeRat IgG2a, κ
ReactivityMouse
ApplicationIHC-F -Quality tested
ClonalityMonoclonal
Clone NumberC068C2
Concentration0.5 mg/mL
TargetCD206
ImmunogenRecombinant mouse CD206 (MMR)
PurityThe antibody was purified by affinity chromatography and conjugated with Spark YG™ 570 under optimal conditions.
FormulationPhosphate-buffered solution, pH 7.2, containing 0.09% sodium azide
StorageThe antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light.Do not freeze.
Regulatory StatusResearch Use Only

Scientific Background

CD206, also known as mannose receptor (MR), is a 175 kD type I membrane protein. It is a pattern recognition receptor (PRR) belonging to the C-type lectin superfamily. MR is expressed on macrophages, dendritic cells, Langerhans cells, and hepatic or lymphatic endothelial cells. MR recognizes a range of microbial carbohydrates bearing mannose, fucose, or N-acetyl glucosamine through its C-type lectin-like carbohydrate recognition domains, sulfated carbohydrate antigens through its cysteine-rich domain, and collagens through its fibronectin type II domain. MR mediates endocytosis and phagocytosis as well as activation of macrophages and antigen presentation. It plays an important role in host defense and provides a link between innate and adaptive immunity. Recently, MR on lymphatic endothelial cells was found to be involved in leukocyte trafficking and a contributor to the metastatic behavior of cancer cells. It suggests that MR may be a potential target in controlling inflammation and cancer metastasis by targeting the lymphatic vasculature.

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.